{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:17:01Z","timestamp":1791908221741,"version":"4.3.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Risk of tuberculosis (TB) declines over time since\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      infection, but progression to clinical disease is still possible decades later. In the United States, most TB cases result from the progression of latent TB infection acquired over 2 years ago.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We synthesized evidence on TB natural history and incidence trends using a transmission-dynamic model. For the 2020 US population, we estimated average time since infection and annual, cumulative, and remaining lifetime risks of progression to TB, by nativity and age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>For a newly infected adult with no other risk factors for progression to TB, estimated rates of progression declined from 38 (95% uncertainty interval: 33, 46) to 0.38 (0.32, 0.45) per 1000 person\u2013years between the first and 25th year since infection. Cumulative risk over 25 years from new infection was 7.9% (7.0, 8.9). In 2020, an estimated average age of individuals with prevalent infection was 62 (61, 63) for the US-born population, 55 (54, 55) for non-US-born, and 57 (56, 58) overall. Average risks of developing TB over the remaining lifetime were 1.2% (1.0, 1.4) for US-born, 2.2% (1.8, 2.6) for non-US-born, and 1.9% (1.6, 2.2) for the general population. Risk estimates were higher for younger age groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our analysis suggests that, although newly infected individuals face appreciable lifetime TB risks, most US individuals with latent TB infection were infected long ago, and face low future risks of developing TB. Better approaches are needed for identifying recently infected individuals and those with elevated progression risks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ede.0000000000001271","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T20:13:47Z","timestamp":1601669627000},"page":"70-78","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":63,"title":["Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States"],"prefix":"10.1097","volume":"32","author":[{"given":"Nicolas A.","family":"Menzies","sequence":"first","affiliation":[{"name":"Harvard T.H. Chan School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Swartwood","sequence":"additional","affiliation":[{"name":"Harvard T.H. Chan School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Testa","sequence":"additional","affiliation":[{"name":"Harvard T.H. Chan School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena","family":"Malyuta","sequence":"additional","affiliation":[{"name":"Harvard T.H. Chan School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Hill","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Marks","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Salomon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"R1-20250801","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/aje\/kwv121","article-title":"A field-validated approach using surveillance and genotyping data to estimate tuberculosis attributable to recent transmission in the United States.","volume":"182","author":"France","year":"2015","journal-title":"Am J Epidemiol"},{"key":"R2-20250801","doi-asserted-by":"crossref","first-page":"e0153728","DOI":"10.1371\/journal.pone.0153728","article-title":"Recent transmission of tuberculosis - United States, 2011-2014.","volume":"11","author":"Yuen","year":"2016","journal-title":"PLoS One"},{"key":"R3-20250801","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: US preventive services task force recommendation statement.","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"R7-20250801","first-page":"490","article-title":"Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts.","volume":"85","author":"Ferebee","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"R8-20250801","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection.","volume":"119","author":"Vynnycky","year":"1997","journal-title":"Epidemiol Infect"},{"key":"R9-20250801","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/infdis\/jiy265","article-title":"Risk and timing of tuberculosis among close contacts of persons with infectious tuberculosis.","volume":"218","author":"Reichler","year":"2018","journal-title":"J Infect Dis"},{"key":"R10-20250801","doi-asserted-by":"crossref","first-page":"k2738","DOI":"10.1136\/bmj.k2738","article-title":"Revisiting the timetable of tuberculosis.","volume":"362","author":"Behr","year":"2018","journal-title":"BMJ"},{"key":"R11-20250801","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/thoraxjnl-2018-211715","article-title":"Evaluating latent tuberculosis infection diagnostics using latent class analysis.","volume":"73","author":"Stout","year":"2018","journal-title":"Thorax"},{"key":"R13-20250801","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"R14-20250801","doi-asserted-by":"crossref","first-page":"e1002814","DOI":"10.1371\/journal.pmed.1002814","article-title":"Predicting progression to active tuberculosis: a rate-limiting step on the path to elimination.","volume":"16","author":"Lalvani","year":"2019","journal-title":"PLoS Med"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/S0140-6736(16)32070-0","article-title":"Predicting tuberculosis risk.","volume":"388","author":"Kik","year":"2016","journal-title":"Lancet"},{"key":"R17-20250801","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.2196\/publichealth.4991","article-title":"The US national tuberculosis surveillance system: a descriptive assessment of the completeness and consistency of data reported from 2008 to 2012.","volume":"1","author":"Yelk Woodruff","year":"2015","journal-title":"JMIR Public Health Surveill"},{"key":"R18-20250801","doi-asserted-by":"crossref","first-page":"e0140881","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis infection in the United States: prevalence estimates from the national health and nutrition examination survey, 2011-2012.","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"key":"R19-20250801","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ije\/dyr058","article-title":"The incubation period distribution of tuberculosis estimated with a molecular epidemiological approach.","volume":"40","author":"Borgdorff","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R20-20250801","doi-asserted-by":"crossref","first-page":"l5770","DOI":"10.1136\/bmj.l5770","article-title":"Is Mycobacterium tuberculosis infection life long?.","volume":"367","author":"Behr","year":"2019","journal-title":"BMJ"},{"key":"R21-20250801","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"R22-20250801","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exger.2017.12.021","article-title":"Tuberculosis in the elderly: why inflammation matters.","volume":"105","author":"Piergallini","year":"2018","journal-title":"Exp Gerontol"},{"key":"R23-20250801","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Engl J Med"},{"key":"R24-20250801","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jama.1995.03530020061033","article-title":"Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA).","volume":"274","author":"Antonucci","year":"1995","journal-title":"JAMA"},{"key":"R25-20250801","doi-asserted-by":"crossref","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","article-title":"Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.","volume":"9","author":"Suthar","year":"2012","journal-title":"PLoS Med"},{"key":"R26-20250801","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/cir951","article-title":"Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis.","volume":"54","author":"Andrews","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R27-20250801","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/aje\/kwy094","article-title":"Prospects for tuberculosis elimination in the United States: results of a transmission dynamic model.","volume":"187","author":"Menzies","year":"2018","journal-title":"Am J Epidemiol"},{"key":"R28-20250801","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201907-1289OC","article-title":"Comparative modelling of tuberculosis epidemiology and policy outcomes in California.","volume":"201","author":"Menzies","year":"2019","journal-title":"Am J Resp Crit Care Med"},{"key":"R29-20250801","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1016\/S1473-3099(18)30134-8","article-title":"Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions.","volume":"18","author":"Menzies","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R30-20250801","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.5588\/ijtld.17.0185","article-title":"The impact of migration on TB in the United States.","volume":"22","author":"Menzies","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"R32-20250801","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0272989X13493143","article-title":"Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial.","volume":"35","author":"Jackson","year":"2015","journal-title":"Med Decis Making"},{"key":"R33-20250801","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40273-017-0494-4","article-title":"Bayesian methods for calibrating health policy models: a tutorial.","volume":"35","author":"Menzies","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"R34-20250801","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/01621459.2000.10474324","article-title":"Inference for deterministic simulation models: The Bayesian melding approach.","volume":"95","author":"Poole","year":"2000","journal-title":"J Am Stat Assoc"},{"key":"R35-20250801","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1541-0420.2010.01399.x","article-title":"Estimating and projecting trends in HIV\/AIDS generalized epidemics using incremental mixture importance sampling.","volume":"66","author":"Raftery","year":"2010","journal-title":"Biometrics"},{"key":"R36-20250801","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/aje\/kwt246","article-title":"Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup.","volume":"179","author":"Shea","year":"2014","journal-title":"Am J Epidemiol"},{"key":"R37-20250801","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm0895-815","article-title":"The intrinsic transmission dynamics of tuberculosis epidemics.","volume":"1","author":"Blower","year":"1995","journal-title":"Nat Med"},{"key":"R38-20250801","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2105\/AJPH.52.6.1002","article-title":"The use of mathematical models in the study of the epidemiology of tuberculosis.","volume":"52","author":"Waaler","year":"1962","journal-title":"Am J Public Health Nations Health"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:10:06Z","timestamp":1754061006000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001271","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,29]]}}}